18 Sep 2025 | 5 Mins Read
Pharma stock surges on USFDA facility approval
Flipitmoney
NATCO Pharma's Hyderabad facility received a USFDA EIR with "Voluntary Action Indicated" classification. The company terms the inspection procedural and assures compliance measures. Shares jumped 5% during trading, with NATCO Pharma emphasizing its focus on R&D for niche and complex products as a leading vertically integrated pharmaceutical company.